SSVEP Evaluation of Brain Function

Sponsor
Headsafe MFG (Industry)
Overall Status
Active, not recruiting
CT.gov ID
NCT05614570
Collaborator
(none)
1,000
1
51
19.6

Study Details

Study Description

Brief Summary

The investigational device used in this clinical investigation, the Nurochek Headset, is a portable electroencephalogram (EEG) headset which delivers a visual stimulus and measures a VEP. The visual stimulus is delivered to the subjects' eyes via light-emitting diodes, and the EEG measures the user's visual-evoked potential. This headset communicates with an application on a smartphone which processes the signals and transmits them to a secure cloud server for analysis and storage of the data.

The primary objective of this clinical investigation was to evaluate the performance of the investigation device (NCII) against clinical diagnosis and SCAT 5, in the accurate detection of mild traumatic brain injury (mTBI). The primary endpoint outlined for this study was set at the collection of 100 valid investigational device readings from individuals with concussion

The aim of this study was to collect data from 100 readings from individuals with concussion. It was estimate that approximately 10-20% of baselined players would suffer a concussion during the season. There it was estimated there would be a need to baseline 500-1000 individuals in order to achieve the number of concussions required. The initial assumption was that sites would provide players pre-season and make players available for testing post-concussion. In practice, some sites provided player data only post-concussion event (such as medical clinics). Participants were required from sporting clubs, medical clinicals and schools.

Condition or Disease Intervention/Treatment Phase
  • Device: SSVEP Device
  • Other: SCAT5

Study Design

Study Type:
Observational
Anticipated Enrollment :
1000 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
SSVEP Evaluation of Brain Function
Actual Study Start Date :
Jan 1, 2019
Anticipated Primary Completion Date :
Apr 1, 2023
Anticipated Study Completion Date :
Apr 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Baseline

This cohort contains individuals tested at baseline, usually in the pre-season of their sporting season

Device: SSVEP Device
Non-invasive, non-interventional SSVEP sensor device
Other Names:
  • Nurochek
  • Other: SCAT5
    The Sport Concussion Assessment Tool version 5

    Concussed

    This cohort contains individuals who have had a concussion, diagnosed by a doctor.

    Device: SSVEP Device
    Non-invasive, non-interventional SSVEP sensor device
    Other Names:
  • Nurochek
  • Other: SCAT5
    The Sport Concussion Assessment Tool version 5

    Outcome Measures

    Primary Outcome Measures

    1. Steady State Visual Evoked Potential [30 days]

      A measure of the steady state visual evoked potential (SSVEP) from the device

    2. SCAT5 Score [30 days]

      The score from the SCAT5 as determined at Step 6.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    14 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Individuals aged 14 years and older, participating in sport-related activities.
    Exclusion Criteria:
    • Individuals were excluded if they had a history of seizures, history of epilepsy, structural brain injuries, legal blindness, or sensitivity to flashing lights.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Headsafe Sydney Australia

    Sponsors and Collaborators

    • Headsafe MFG

    Investigators

    • Principal Investigator: Craig Donaldson, MBBS, Principal Investigator

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Headsafe MFG
    ClinicalTrials.gov Identifier:
    NCT05614570
    Other Study ID Numbers:
    • 2018-10-891
    First Posted:
    Nov 14, 2022
    Last Update Posted:
    Nov 14, 2022
    Last Verified:
    Nov 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Keywords provided by Headsafe MFG
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 14, 2022